Evidence map›Paper›PMID 26083787›Full record

ArticlePloS one2015

Sleep Quality of Patients with Differentiated Thyroid Cancer.

Yajing He, Zhaowei Meng, Qiang Jia, Fang Hu, Xianghui He, Jian Tan, Guizhi Zhang, Xue Li, Jianping Zhang, Qing Zhang and 14 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03757637 naunknown statusnot on this mapstarted 2018, after this paper: background citation

Yeur-Hur Lai, PhD, RN, School of Nursing, College of Medicine, National Taiwan University

TypeinterventionalSponsorNational Taiwan University HospitalRan2018 to 2025Enrolled380ConditionsDifferentiated Thyroid CancerArmsNLSCP, ICT supported HAP
NCT05739968 narecruitingnot on this mapstarted 2021, after this paper: background citation

Impacts and Testing of the "Multi-domains Active-living Program (MAP)" in Newly Diagnosed Operable Non-Muscle Invasive Bladder Cancer Patients - Current Status and the Effects of Combining With eHealth-Enhanced Randomized Controlled Trial

TypeinterventionalSponsorNational Taiwan University HospitalRan2021 to 2026Enrolled120ConditionsBladder Cancer, Quality of LifeArmsUsual care + oncology case manager (OCM) care, Multi-domains Active-living Program (MAP) with e-health enhanced intervention + usual care + oncology case manager (OCM) care
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. The challenges experienced by patients in the early period after thyroidectomy and the effects on sleep quality.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Sleep quality, stress and thyroid cancer: a case-control study.Journal of endocrinological investigation · 2022
    Article
  15. Article
  16. Impact of sleep disorders in cognitive function of thyroid cancer survivors.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2017
    Article
  17. Observational
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 1 institution in 1 country.

Yajing HeDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Zhaowei MengDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Qiang JiaDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Fang HuDepartment of General Surgery, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Xianghui HeDepartment of General Surgery, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Jian TanDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Guizhi ZhangDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Xue LiDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Jianping ZhangDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Qing ZhangDepartment of Health Management, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Li LiuDepartment of Health Management, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Lili ZhaoDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Jing LiDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Yuling WangDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Yumei QianDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Shuling HouDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Hua LiuDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Sheng WangDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Renfei WangDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Wei ZhengDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Tianpeng HuDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Na LiuDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Arun UpadhyayaDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Yang LiuDepartment of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin, P. R. China.
Tianjin Medical University General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe aimed to measure prevalence of sleep disturbance in patients with differentiated thyroid cancer (DTC) by calculating Pittsburgh Sleep Quality Index (PSQI), and compare these data with patients with benign thyroid nodules or normal participants.

methodsThree groups of patients participated in this cross-sectional study. In the first group, 162 patients with DTC received total thyroidectomy, and then 131I therapy. The second group consisted of 84 patients with benign thyroid nodules, who received partial thyroidectomy. The third group was 78 normal healthy control cases. PSQI was used to assess the sleep quality. Inter-group differences were analyzed by Kruskal-Wallis test or independent samples T test. χ2 test was also used to check prevalence differences of poor sleep quality among the groups. Differences of PSQI score and poor sleep quality prevalence before and after 131I therapy in the same group of DTC participants were analyzed by paired T test and Mcnemar's test.

resultsHigher PSQI score (7.59 ± 4.21) and higher rate of poor sleep quality (54.32%) were shown in DTC patients than in any other group. After 131I therapy, PSQI score and prevalence of poor sleep quality in DTC patients increased significantly to 8.78 ± 4.72 and 70.99%. Then DTC patients were divided into two subgroups based on their metastatic status. DTC patients with metastasis (87/162 cases, 53.70%) had significantly higher PSQI score (10.87 ± 5.18) and higher prevalence of poor sleep quality (79.31%).

conclusionDTC patients suffer from sleep disturbance, 131I therapy and awareness of metastatic status could worsen sleep problem. Psychological fear of cancer, nuclear medicine therapy and metastasis could be one major underlying reason. Longitude and interventional studies are necessary for further investigations.

Indexed as

Cell DifferentiationAdenocarcinomaAdultChinaCross-Sectional StudiesFemaleHumansMalePrevalenceSleep Wake DisordersSurveys and QuestionnairesThyroid Neoplasms

Identifiers

PMID26083787
PMCPMC4471198
OpenAlexW1587215270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.